Diseases, Conditions, Syndromes

Shorter tuberculosis treatment not a successful alternative

A clinical drug trial conducted in five Sub-Sahara African countries shows that a shortened (four month) treatment for tuberculosis (TB) is well tolerated and may work well in subsets of TB patients, but overall could not ...

Diseases, Conditions, Syndromes

Antibiotics do not shorten tuberculosis treatment, finds Phase 3 trial

The results of a Phase 3 clinical trial involving UCL researchers, called REMoxTB, has found that replacing one of the drugs with the antibiotic moxifloxacin in the standard six-month treatment regimen did not allow the treatment ...

Diseases, Conditions, Syndromes

WHO targets elimination of tuberculosis in over 30 countries

The World Health Organization (WHO) today, together with the European Respiratory Society (ERS), presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33* countries ...

Diseases, Conditions, Syndromes

China halves tuberculosis prevalence in just 20 years

Over the last 20 years, China has more than halved its tuberculosis (TB) prevalence, with rates falling from 170 to 59 per 100 000 population. This unrivalled success has been driven by a massive scale-up of the directly ...

Diseases, Conditions, Syndromes

Virtual monitoring could aid adherence to TB medication

Virtual observation of patients taking their prescribed TB medication, could prove an effective technique for ensuring patients effectively complete their course of treatment.

page 6 from 9